MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, and Heart Imaging Technologies (Heart IT), an industry leader in web-based medical image viewing and management solutions, are pleased to announce their strategic partnership and the integration of Heart IT's WebPAX® technology with MedNet's eClinical solutions.
Tiny sensors and motors are everywhere, telling your smartphone screen to rotate and your camera to focus. Now, a team of researchers at Tel Aviv University has found a way to print biocompatible components for these micro-machines, making them ideal for use in medical devices, like bionic arms.
Stryker Interventional Spine announced the clearance of 510(k)s for two additional products to its portfolio. Venom RF Cannula and Venom Electrode are designed to provide an effective and minimally invasive treatment for facet joint pain. The launch of the 11g iVAS Balloon System addresses the surgical trend of shifting toward less invasive treatment options.
Boston Scientific shipped some of its Promus Element Plus Monorail coronary stents with the wrong labels in Australia, prompting that country's Therapeutic Goods Administration to issue a recall. The Promus stents were shipped with incorrect directions for use Down Under, according to a TGA release.
The Journal of Visualized Experiments has published two new methods for scientists to study and treat tumor growth. The methods introduce a lab-born, human tissue structure with replicated human biochemistry – offering scientists the opportunity to grow, observe, and ultimately learn how to treat biopsied human tumor cells.
The Large Area Picosecond Photodetector collaboration has developed big detectors that push the timing envelope, measuring the speed of particles with a precision down to trillionths of a second. Potential applications for the photodetector range from basic X-ray physics to medical imaging.
Royal Philips today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Pinnacle³ Proton treatment planning system in the U.S. Philips’ Pinnacle³ is a recognized treatment planning system for external beam radiotherapy, which provides accuracy and reliability to users independent of the treatment delivery system.
In a complex sequence of spin-offs, name-changes and mergers, the dust has settled for vision correction company GlassesOff, formerly called Autovative Products and recently restructured through a merger with software company Ucansi. The former Autovative Products also created a spin-off, Autovative Technologies, which will be headed by former CEO David Funderburk.
New Johns Hopkins research suggests that people who undergo minimally invasive placement of stents to open clogged leg arteries are significantly less likely than those who have conventional bypass surgery to need a second treatment for the condition within two years.
Ground-breaking research is harnessing the unique properties of diamonds to develop a new generation of lasers that could lead to many benefits, from better treatment of skin complaints and diabetes-related eye conditions to improved pollution monitoring and aeronautical engineering.
Throbbing pain may pound like a heartbeat, but University of Florida scientists have discovered the sensation is all in your head, or more precisely, in your brain waves. The finding could drastically change how researchers look for therapies that can ease pain.
Qualcomm Incorporated, through its Qualcomm Wireless Reach™ initiative, Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated, and Rady Children’s Hospital, the primary pediatric health provider serving San Diego, Imperial and southern Riverside counties, today announced their collaboration on a 3G-enabled kit for monitoring the activities of asthmatic children.
Enhancing and manipulating the light emission of organic molecules is at heart of many important technological and scientific advances, including in the fields of organic light emitting devices, bio-imaging, bio-molecular detection. Researchers at MIT have now discovered a new platform that enables dramatic manipulation of the emission of organic molecules...
VeriTeQ Partners with Establishment Labs, S.A. d/b/a Motiva, to Manufacture and Market World’s First Breast Implants with VeriTeQ’s Microchip – “Q Inside”August 7, 2013 9:00 am | by Business Wire | News | Comments
Digital Angel Corporation, a provider of implantable medical device identification and radiation dose measurement technologies following its recent share exchange with VeriTeQ Acquisition Corporation, announced that Establishment Labs, S.A. (“EL”), d/b/a Motiva, is now ready to market the world’s first traceable breast implant with Q Inside
Quanterix Corporation, delivering the world’s most sensitive single molecule immunoassay measurement for the benefit of human health, today announced that the Simoa HD-1 Analyzer recently launched by Quanterix uses a “Smart Consumable” designed and manufactured by Sony DADC BioSciences called the Simoa Disc.